Indeed, we found that EMC6 enhanced the autophagy level in GBM cells by downregulating the phosphatidylinositol 3-kinase (PIK3CA)/protein kinase B (AKT) and the mammalian target of rapamycin (mTOR) pathways. The gene discussed is MTOR; the disease is glioblastoma.